The global smart inhalers market size was US$ 147.7 million in 2021. The global smart inhalers market size is forecast to reach US$ 1,116.5 million by 2030, growing at a compound annual growth rate (CAGR) of 25.2% during the forecast period from 2022 to 2030.

Request To Download Sample of This Strategic Report :-

Smart inhalers deliver various drugs by inhalation. The drugs used in inhalers in order to treat or prevent respiratory conditions, like asthma and chronic obstructive pulmonary disease (COPD), include anticholinergics, glucocorticoids, insulin, and beta-agonists. The sensors attached as a clip-on to these inhalers measure the right dose per intake and the technique used when inhaling the medication, thus making them smart inhalers. Some smart inhalers feature sensors that can detect polluted or pollen-filled environments, send helpful reminders, and tell if a user’s inhaler technique needs to be adjusted. Since they all automatically measure how frequently individuals use their inhalers, individuals do not have to keep their own records.

Factors Influencing Market Growth

A major factor driving the growth of the smart inhalers market is the rise in asthma and COPD prevalence. In addition, air pollution and an increase in indoor air pollutants further increase the chances of developing respiratory disorders.

Improved treatment options, ease of use, and technological developments, combined with an increase in adherence rates among patients, are major factors driving the market for smart inhalers.

Data misuse and breach of data privacy, high cost of asthma & COPD treatment, and low awareness of smart inhalers may slow down the overall market growth.

There are many opportunities for market growth during the forecast period due to the high market potential in untapped emerging economies, the rise in the number of product launches, partnerships, collaborations among government agencies and key players, and the development of pipeline products.

Impact Analysis of COVID-19

COVID-19 outbreak had a positive effect on the smart inhaler market. A vast number of hospitals and clinics worldwide have redesigned their facilities to increase capacity for patients with COVID-19. Because of COVID-19’s rapid rise, non-essential procedures took a possible backlog. The lockdown disrupted transportation and manufacturing of healthcare essentials. The rise in chronic respiratory diseases led to an increase in hospital visits and clinical visits, resulting in an increase in demand for inhalers and nebulizers, propelling the market growth.

Request To Download Sample of This Strategic Report :-

Regional Insights

In 2021, North America held the leading global market share for smart inhalers and is forecast to continue dominating over the forecast period. A number of factors are responsible for the market growth in the region, including better healthcare infrastructure and facilities, a high prevalence of asthma and COPD patients, technologically advanced treatments, the presence of players in the healthcare system, and an increase in healthcare expenditures.

The Asia Pacific is forecast to grow significantly during the forecast period. As a result of its high geriatric population base, the increase in disposable income, and various development activities. Furthermore, India and China will grow at a rapid CAGR in the Asia-Pacific smart inhalers market.

Leading Competitors

The leading prominent companies profiled in the global smart inhalers market are:

Adherium Limited

Aptar Group Incorporated (Cohero Health Inc.)

AstraZeneca, Incorporated

Cognita Labs, LLC

GlaxoSmithKline Plc

Novartis AG

OPKO Health Incorporated

Philip Morris International Incorporated (Vectura Group Plc)

Resmed Inc. (Propeller Health)

Teva Pharmaceutical Industries Limited

Other Prominent Players

Scope of the Report

The global smart inhalers market segmentation focuses on Product, Indication, Distribution Channel, and Region.

Segmentation based on Product


Dry Powdered Inhalers (DPIs)

Metered Dose Inhalers (MDIs)


Segmentation based on Indication


Chronic obstructive pulmonary disease (COPD)

Segmentation based on Distribution Channel

Hospitals Pharmacies

Retail Pharmacies

Get a Sample PDF copy of the report :-

Segmentation based on Region

North America

The U.S.




Western Europe

The UK





Rest of Western Europe

Eastern Europe



Rest of Eastern Europe

Asia Pacific




Australia & New Zealand


Rest of Asia Pacific

Middle East & Africa (MEA)


Saudi Arabia

South Africa

Rest of MEA

South America



Rest of South America

What are the key findings of the report?
?This report provides comprehensive information on factors expected to influence the market growth and market share in the future.
?The report offers the current state of the market and future prospects for various geographical regions.
?This report provides both qualitative and quantitative information about the competitive landscape of the market.

Access full Report Description, TOC, Table of Figure, Chart, etc.-

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:
Report Ocean:
Email: [email protected]
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES Tel: +1 888 212 3539 (US – TOLL FREE)

Source link